Komori
Sumitomo Seika Chemicals Company,Limited. (4008) · FactGain on sale of investment securities increased

Recognition of Gain on Sale of Investment Securities

First written in FY2023-Q3. 1 of 5 entries say "Restated". Latest entry: FY2026.

5entries
4years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2023-Q3 – FY20262023: 220232024: 120242025: 120252026: 12026
Same theme, other companies
Recognition of gains on sales of investment securities and shares in affiliated companiesA theme 315 companies write about · 1 as a headwind · 338 as a tailwind

83 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 181 companies compared. The sentences above are computed from all 181.Comparing 200 of the theme's 342 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026Gain on sale of investment securities increasedAnnual report

    「The Company recorded a ¥831 million gain on the sale of investment securities as extraordinary income.」

    The gain on the sale of investment securities increased from ¥62 million in the previous fiscal year to ¥831 million.
  2. FY2026-H1Gain on sale of investment securities recordedAnnual report

    「Gain on sale of investment securities — 821」

    While no gain on the sale of investment securities was recorded in the same period of the previous year, ¥821 million was recorded as extraordinary income in the current interim consolidated accounting period.
  3. FY2024-Q3Gain on sale of investment securities decreasedAnnual report

    「Gain on sale of investment securities 429 37」

    The gain on the sale of investment securities decreased from ¥429 million in the same period of the previous year to ¥37 million.
  4. FY2023RestatedAnnual report

    「Extraordinary income amounted to ¥429 million, reflecting the recognition of a ¥429 million gain on the sale of investment securities.」

    The ¥429 million gain on the sale of investment securities reported in Q3 was recorded as extraordinary income for the full fiscal year.
  5. FY2023-Q3First statedAnnual report

    「Gain on sale of investment securities — 429」

    During the nine months ended Q3, the Company recorded a ¥429 million gain on the sale of investment securities as extraordinary income.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Sumitomo Seika Chemicals Company,Limited. yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Recognition of Gain on Sale of Investment Securities | Sumitomo Seika Chemicals Company,Limited. (4008) | Komori